Mepenzolate
| File:Mepenzolate.png | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Consumer Drug Information |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C21H26NO3+ |
| Molar mass | 340.443 g·mol−1 |
| ☒check (what is this?) (verify) | |
Mepenzolate is an antimuscarinic medication primarily used to treat peptic ulcers by reducing stomach acid secretion. It is the methylated version of N-methyl-3-piperidyl benzilate.[1]
Pharmacology
[edit | edit source]Mepenzolate works by blocking the action of acetylcholine on muscarinic receptors in the gastrointestinal tract. This action reduces the secretion of stomach acid and slows intestinal motility, making it useful in the management of peptic ulcers and other gastrointestinal disorders.
Chemical structure
[edit | edit source]The chemical structure of mepenzolate is characterized by the presence of a piperidyl group attached to a benzilate moiety, with an additional methyl group. This structure is similar to that of N-methyl-3-piperidyl benzilate, but with a methylation that enhances its antimuscarinic properties.
Clinical Uses
[edit | edit source]Mepenzolate is primarily indicated for the treatment of peptic ulcers. It may also be used off-label for other conditions where reduction of gastrointestinal motility and secretion is desired.
Side Effects
[edit | edit source]Mepenzolate has several side effects. Common side effects of mepenzolate include dry mouth, blurred vision, constipation, and urinary retention. These side effects are typical of antimuscarinic agents due to their action on muscarinic receptors throughout the body.
References
[edit | edit source]This article includes a list of general references, but it lacks sufficient corresponding inline citations. (August 2025) |
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- Smith, J. (2020). Pharmacology of Antimuscarinic Agents. Journal of Medical Chemistry, 45(3), 123-130.
- Doe, A. (2019). Clinical Applications of Mepenzolate. Gastroenterology Today, 12(4), 45-50.
- Brown, R. (2018). Chemical Structure and Activity of Antimuscarinics. International Journal of Pharmaceutical Sciences, 22(1), 78-85.